is mounjaro a glp-1 receptor agonist use tripled among non-diabetics, reaching $5.8B in 2022 Understanding GLP-1 receptor agonists and

doi: 10.1080/14740338.2018.1428305 [DOI] [PubMed] [Google Scholar] 230.Zafer M, Tavaglione F, Romero-Gmez M, et al

8mg weekly dose The 8mg tier produced 22.8% body weight loss at 48 weeks

in some trials, the incidence was more than 10% higher compared to placebo [14]

Another short-term, randomized, double-blind, placebo-controlled trial in children (mean age 9.9 1.1 years, n = 24) found that 56.3% of liraglutide recipients reported mainly gastrointestinal symptoms and asymptomatic hypoglycemia [66]

It immediately clicked for me that I also wanted to improve my blood work and I should try a GLP-1. For the previous decade, Turners A1C had hovered in the prediabetic range